Chimeric Antigen Receptors Targeting CD-19
Germany
15729304.4
Filed on 2015-06-01
15729304.4
Filed on 2015-06-01
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY
US Patent 11,904,057
Filed on 2020-08-04
Filed on 2020-08-04
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY
Japan
2020-542544
Filed on 2019-02-08
2020-542544
Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY
India
202037038092
Filed on 2019-02-08
202037038092
Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY
European Patent
19707555.9
Filed on 2019-02-08
19707555.9
Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY
China
201980012620.8
Filed on 2019-02-08
201980012620.8
Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY
Canada
3089396
Filed on 2019-02-08
3089396
Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY
Australia
2019216781
Filed on 2019-02-08
2019216781
Filed on 2019-02-08
METHODS OF TREATMENTS USING ANTIGEN-BINDING PROTEINS TARGETING CD56
US Patent 12,018,077
Filed on 2020-06-25
Filed on 2020-06-25
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3
Hong Kong
42020016865.6
Filed on 2020-09-25
42020016865.6
Filed on 2020-09-25